Papa Syndrome clinical trials

Explore recruiting papa syndrome clinical trials.

Also recruiting in Europe

Papa Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A double-blind, placebo-controlled, randomized withdrawal study of canakinumab in pyogenic sterile arthritis pyoderma gangrenosum and acne (PAPA) syndrome

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Papa Syndrome trials by city

Papa Syndrome in Toronto Papa Syndrome in Vancouver Papa Syndrome in Montreal Papa Syndrome in Calgary Papa Syndrome in Edmonton Papa Syndrome in Ottawa Papa Syndrome in Winnipeg Papa Syndrome in Quebec City Papa Syndrome in Hamilton Papa Syndrome in Kitchener Papa Syndrome in London Papa Syndrome in Halifax Papa Syndrome in New York Papa Syndrome in Los Angeles Papa Syndrome in Chicago Papa Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease